As leader of Stanford’s Cancer Computational and Systems Biology group, Christina Curtis, one of In Vivo’s 2021 Rising Leaders, is working to shed new light on the mysteries of metastatic cancer. Curtis’s use of computational models to analyze genetic mutations in breast cancer earned her an NIH Director’s Pioneer Award.
Back To Rising Leaders Gallery
As with many aspects of human biology, the closer one looks, the more complicated and chaotic things become. Not only...
Join thousands of industry professionals who rely on In Vivo for daily insights
Already a subscriber?
Neha Krishnamohan, CFO of Artiva Biotherapeutics, brings Wall Street precision to biotech innovation, helping lead the company through a successful IPO while advancing NK cell therapies for cancer and autoimmune diseases.
As president of US Hematology at J&J, June Lanoue's leadership approach focuses on improving patient outcomes and organizational development. Her career path demonstrates the role of curiosity and adaptability in health care advancement.
Bristol Myers Squibb executive Doxie Jordan discusses his path to global commercial leadership and the principles guiding pharmaceutical market strategy
Ovid Therapeutics' president and COO Meg Alexander is leading the company’s strategic pivot toward innovative neurological treatments, potentially creating a new class of medicines for rare neurological disorders.
Neha Krishnamohan, CFO of Artiva Biotherapeutics, brings Wall Street precision to biotech innovation, helping lead the company through a successful IPO while advancing NK cell therapies for cancer and autoimmune diseases.
As president of US Hematology at J&J, June Lanoue's leadership approach focuses on improving patient outcomes and organizational development. Her career path demonstrates the role of curiosity and adaptability in health care advancement.
Bristol Myers Squibb executive Doxie Jordan discusses his path to global commercial leadership and the principles guiding pharmaceutical market strategy
